Antiglycation Activity of Quinoline Derivatives- A New Therapeutic Class for the Management of Type 2 Diabetes Complications

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|11|1|60-68

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.11, Iss.1, 2015-02, pp. : 60-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes

By Dailey George E  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1417-1430

Informa Healthcare

Access to resources Recommend Favorite

SIRT1, a Calorie Restriction Mimetic, in a New Therapeutic Approach for Type 2 Diabetes Mellitus and Diabetic Vascular Complications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 1, 2010-03 ,pp. : 16-24

Bentham Science Publishers

Access to resources Recommend Favorite

Oxindole Derivatives: Synthesis and Antiglycation Activity

By  

Medicinal Chemistry, Vol. 9, Iss. 5, 2013-08 ,pp. : 681-688

Bentham Science Publishers

Access to resources Recommend Favorite

Resistin: A Promising Therapeutic Target for the Management of Type 2 Diabetes Mellitus?

By  

Drug Design Reviews - Online, Vol. 2, Iss. 1, 2005-02 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite

Glucokinase activators as new type 2 diabetes therapeutic agents

By Sarabu Ramakanth   Berthel Steven J   Kester Robert F   Tilley Jefferson W  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 759-768

Informa Healthcare

Access to resources Recommend Favorite